Refractive surgeries are advanced medical procedures designed to correct vision problems and reduce dependence on glasses or contact lenses. These surgeries work by reshaping the eye or adding corrective lenses to improve how light is focused onto the retina. With continuous advancements in technology, refractive surgeries have become safe, effective, and widely used across the world. visit herE:- https://asgeyehospital.com/specialities/refractive-surgeries/

Global Medical ePTFE Tubing Market Forecast 2025: Revenue Insights According to a newly published 24LifeSciences market research report, Global Medical ePTFE Tubing Market was valued at USD 216 million in 2024 and is projected to reach USD 356 million by 2031, growing at a 7.0% CAGR during the forecast period 2025-2031. Expanded Polytetrafluoroethylene (ePTFE) tubing is a high-performance fluoropolymer product known for its exceptional biocompatibility, chemical resistance, and low friction coefficient. These properties make it an indispensable component in advanced medical applications where device longevity and patient safety are non-negotiable. The material's inherent inertness prevents adverse immune reactions, making it ideal for prolonged implantation and contact with bodily fluids. Its versatility supports a wide range of critical medical procedures from cardiovascular interventions to complex surgical applications. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4071/medical-eptfe-tubing-market

AI & Molecular Diagnostics Reshaping Cervical Cancer Screening Market According to a newly published market research report by 24LifeSciences, global cervical cancer diagnostic testing market was valued at USD 6.19 billion in 2025 and is projected to grow from USD 6.47 billion in 2026 to reach USD 8.44 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period. Cervical cancer diagnostic tests are essential medical procedures designed to detect precancerous and cancerous conditions in the cervix. These tests are critical for early intervention because cervical cancer is primarily caused by persistent infection with high-risk human papillomavirus (HPV) strains. The primary diagnostic modalities include Pap smear tests (Pap cytology), HPV DNA tests, colposcopy, and cervical biopsies, which are fundamental components of routine gynecological screening programs worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9355/cervical-cancer-diagnostic-testing-market